Su1411: DIAGNOSIS AND THERPEUTIC MONITORING OF PATIENTS WITH BILE ACID SYNTHESIS DISORDERS BY A NOVEL TARGETED QUANTITATIVE TANDEM MASS SPECTROMETRY ASSAY OF ATYPICAL BILE AICD BIOMARKERS

MLA

Kenneth D. Setchell, et al. “Su1411: DIAGNOSIS AND THERPEUTIC MONITORING OF PATIENTS WITH BILE ACID SYNTHESIS DISORDERS BY A NOVEL TARGETED QUANTITATIVE TANDEM MASS SPECTROMETRY ASSAY OF ATYPICAL BILE AICD BIOMARKERS.” Gastroenterology, vol. 162, May 2022, p. S-1212. EBSCOhost, https://doi.org/10.1016/s0016-5085(22)63589-3.

APA

Kenneth D. Setchell, Junfang Zhao, & Wujuan Zhang. (2022). Su1411: DIAGNOSIS AND THERPEUTIC MONITORING OF PATIENTS WITH BILE ACID SYNTHESIS DISORDERS BY A NOVEL TARGETED QUANTITATIVE TANDEM MASS SPECTROMETRY ASSAY OF ATYPICAL BILE AICD BIOMARKERS. Gastroenterology, 162, S-1212. https://doi.org/10.1016/s0016-5085(22)63589-3

Chicago

Kenneth D. Setchell, Junfang Zhao, and Wujuan Zhang. 2022. “Su1411: DIAGNOSIS AND THERPEUTIC MONITORING OF PATIENTS WITH BILE ACID SYNTHESIS DISORDERS BY A NOVEL TARGETED QUANTITATIVE TANDEM MASS SPECTROMETRY ASSAY OF ATYPICAL BILE AICD BIOMARKERS.” Gastroenterology 162 (May): S-1212. doi:10.1016/s0016-5085(22)63589-3.